OpenAI expands GPT-6 lineup with cheaper Sol and Luna models

Transportation secretary says he doesn’t apologize for FAA’s nationwide ground stop

A Larger-Than-Normal Fed Rate Hike in December Now Looks More Likely. Here's Why.

The hottest job in AI right now may be counterintelligence as companies hire to protect secrets

How Nvidia's scandal knocked thousands off your 401(k)

FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class

The United States Food and Drug Administration has rejected Summit Therapeutics and Akeso's lung cancer drug ivonescimab.

Outlook Went Down? Microsoft May Owe You Money